Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the ...

These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of the Nevro business, trends in the medical industry and the ability of Globus ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) on April 15 and set a price target ...

Globus Medical (GMED), which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider. This medical device company has seen a nice streak of beating earnings ...

Globus Medical GMED has outperformed the market over the past 10 years by 1.4% on an annualized basis producing an average annual return of 11.03%. Currently, Globus Medical has a market ...

Globus Medical, Inc. (NYSE: GMED) will release its first-quarter 2025 financial results on Thursday, May 8, 2025, after ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...